Do autologous mesenchymal stem cells augment bone growth and contact to massive bone tumor implants?

Tissue Engineering

Volumn 12, Issue 6, 2006, Pages 1617-1626

  Kalia, Priya ^a   Blunn, Gordon W ^a   Miller, Jemima ^a   Bhalla, Aprajit ^a   Wiseman, Michael ^a   Coathup, Melanie J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; GROWTH KINETICS; HISTOLOGY; MATHEMATICAL MODELS; RADIOGRAPHY; SURGERY; TUMORS;

BONE MARROW; IMPLANT FIXATION; MESENCHYMAL STEM CELLS (MSCS); OVINE;

CELLS;

FIBRIN GLUE; HYDROXYAPATITE;

ANIMAL CELL; ARTICLE; BONE GROWTH; BONE RADIOGRAPHY; BONE TUMOR; CANCER GRAFT; CELL PROLIFERATION; CELL VIABILITY; ENDOPROSTHESIS; FRACTURE FIXATION; HISTOPATHOLOGY; IMPLANT; JOINT PROSTHESIS; MESENCHYME CELL; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; PROSTHESIS LOOSENING; SHEEP; STEM CELL; TELEMETRY; WEIGHT BEARING;

ANIMALS; BONE NEOPLASMS; BONE REGENERATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; FEMALE; FEMUR; MESENCHYMAL STEM CELLS; PROSTHESES AND IMPLANTS; SHEEP; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

OVIS;

EID: 33746858092     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.12.1617     Document Type: Article

References (41)

1. Blunn, G.W., Briggs, T.W.R., Cannon, S.R., Walker, P.S., Unwin, P.S., Culligan, S., and Cobb, J.P. Cementless fixation for primary segmental bone tumour endoprosthesis. Clin. Orthop. Res. 1, 223, 2000.
2. Blunn, G.W., and Wait, M.E. Remodelling of bone around intramedullary stems growing patients. Orthop. Res. 9, 809, 1991.
3. Ward, W.G., Johnston, K.S., Dorey, F.J., and Eckardt, J.J. Loosening of massive proximal femoral cemented endoprostheses. J. Arthroplasty 12, 741, 1997.
4. Taylor, S.J.G., Perry, J.S., Meswania, J.M., Donaldson, N., Walker, P.S., and Cannon, S.R. Telemetry of forces from proximal femoral replacements and relevance to fixation. J. Biomechanics 30, 225, 1997.
5. Ward, W.G., Eckardt, J.J., Johnston-Jones, K.S., Eiber, F.R., Namba, R., Dorey, F.J., Mirra, J., and Kabo, J.M. Five to ten year results of custom endoprosthetic replacement for tumours of distal femur. In: Brown, K.L.B., ed. Complications of limb-salvage. Prevention, management and outcome. Montreal: ISOLS, 1991, p. 483.
6. Schmalzried, T.P., Jasty, M., and Harris, W.H. Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of the effective joint space. J Bone Joint Surg 74A, 849, 1992.
7. Ward, W., Johnston, K., Dorey, F., and Echardt, J. Extramedullary porous coating to prevent diaphyseal osteolysis and radiolucent lines around proximal tibial replacements. J. Bone Joint Surg. 75A, 976, 1993.
8. Unwin, P.S., Walker, P.S., Brigg, T.W., Cannon, S.R., Carter, S.R., Cobb, J., Grimer, R.J., and Blunn, G.W. Rotated hinged, hydroxyapatite coated versus fixed hinged, uncoated distal femoral replacements. A study of 402 cases. Proc. 10th Intl Symp on Limb Salvage, Cairns, Australia, 1999.
9. Caplan, A.I. Mesenchymal stem cells. J. Orthop. Res. 9, 641, 1991.
10. Bruder, S.P., Neelam, J., and Haynesworth, S.E. Growth kinetics, self-renewal and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J. Cell Biol. 64, 278, 1997.
11. Caplan, A.I. The mesengenic process. Clin. Plastic Surg. 21, 429, 1994.
12. Goshima, J., Goldberg, V.M., and Caplan, A.I. The osteogenic potential of culture-expanded rat marrow mesenchymal cells assayed in vivo in calcium phosphate ceramic blocks. Clin. Orthop. 262, 298, 1991.
13. Haynesworth, S.E., Goshima, J., Goldberg, V.M., and Caplan, A.I. Characterisation of cells with osteogenic potential from human marrow. Bone 13, 81, 1992.
14. Pittenger, M.F., Mackey, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
15. Owen, M.E., and Freidenstein, A.J. Stromal stem cells: Marrow derived osteogenic precursors. In: Evered, D., and Harnett, S., eds. Cell and Molecular Biology of Vertebrate Hard Tissues. Chichester: Wiley, 1988, pp. 42-60.
16. Kadiyala, S., Jaiswal, N., and Bruder, S.P. Culture-expanded, bone marrow-derived mesenchymal stem cells can regenerate a critical sized segmental bone defect. Tissue Eng. 3, 173, 1997.
17. Horowitz, E.M., Prockop, D.J., Fitzpatrick, L.A., Koo, W.W.K., Gordon, P.L., and Neel, M. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 5, 309, 1999.
18. Lazarus, H.M., Haynesworth, S.E., Gerson, S.L., Rosenthal, N.S., and Caplan, A.I. Ex vivo expansion and subsequent infusion of human bone marrow derived stromal progenitor cells (mesenchymal progenitor cells): Implications for therapeutic use. Bone Mar. Transp. 16, 557, 1995.
19. Satomura, K., and Nagayam, M. Ultrastructure of mineralised nodules formed in rat bone marrow stromal cell culture in vitro. Acta. Anat. 142, 97, 1991.
20. Bruder, S.P., Kraus, K.H., Goldberg, V.M., and Kadiyala, S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J. Bone Joint Surg. 80A, 985, 1998.
21. Okada, Y., Suka, T., Sim, F., Gorski, J., and Chao, E. Comparison replacement prostheses for segmental defects in bone. J Bone Joint Surg 70A, 160, 1988.
22. Chao, E.Y.S., and Sim, F.H. Modular prosthetic system for segmental bone and joint replacement after tumour resection. Orthopaedics 8, 641, 1985.
23. Cobb, J.P., Unwin, P.S., Walker, P.S., and Blunn, G.W. Extracortical bone bridging to enhance fixation. In: Brown, K.L.B., ed. Complications of Limb Salvage: Prevention, Management and Outcome. Montreal: ISOLS, 1991, pp. 409-411.
24. Leung, K.S., Cheung, W.H., Yeung, H.Y., Lee, K.M., and Fung, K.P. Effect of weightbearing on bone formation during distraction osteogenesis. Clin. Orthop. 419, 251, 2004.
25. Wright, K.W.J., and Meswania, J.M. Stem:PMMA fixation of proximal femoral replacements: biochemical and clinical findings. Proceedings of the IMechE. C218/84:45-54, 1984.
26. Inglis, A., and Walker, P.S. Long term radiographic evaluation of proximal femoral replacements. In: Langlais, F., and Tomeno, B., eds. Limb Salvage: Major Reconstructions in Oncologic and Nontumoural Conditions. Berlin: Springer-Verlag, pp. 257-262, 1989.
27. Keller, J., Anderassen, T.T., and Joyce, F. Fixation of osteochondral fractures: fibrin sealant tested in dogs. Acta Orthop. Scand. 56, 323, 1985.
28. Martl, W., and Rubas, B. The effect of factor XIII on wound granulation in the rat. Thromb. Diath. Haemorrh. 32, 578, 1974.
29. Kasai, S., Kunimoto, T., and Nitta, K. Cross-linking of fibrin by activated factor XIII stimulates attachment, morphological changes and proliferation of fibroblasts. Biomed. Res. 4, 155, 1983.
30. Schwarz, N. The role of fibrin sealant in osteoinduction. Ann. Chir. Gynaecol. Suppl. 207, 63, 1993.
31. Schwarz, N., Redl, H., Zeng, L., Schlag, G., Dinges, H.P., and Eschberger, J. Early osteoinduction in rats is not altered by fibrin sealant. Clin. Orthop. 293, 353, 1993.
32. Tholpady, S.S., Schlosser, R., Spotnitz, W., Ogle, R.C., and Lindsey, W.H. Repair of an osseous facial critical-size defect using augmented fibrin sealant. Laryngoscope 109, 1585, 1999.
33. Isogai, N., Landis, W.J., Mori, R., Gotoh, Y., Gerstenfeld, L.C., Upton, J., and Vacanti, J.P. Experimental use of fibrin glue to induce site-directed osteogenesis from cultured periosteal cells. Plast. Reconstr. Surg. 105, 953, 2000.
34. Abiraman, S., Varma, H.K., Umashankar, P.R., and John, A. Fibrin glue as an osteoinductive protein in a mouse model. Biomaterials 23, 3023, 2002.
35. Lee, O. K.-S., Coathup, M.J., Goodship, A.E., and Blunn, G.W. Use of mesenchymal stem cells to facilitate bone regeneration in normal and chemotherapy-treated rats. Submitted to J. Tissue Eng. 11, 1727, 2005.
36. Bartholomew, A., Sturgeon, C., Slatskas, M., Ferrer, K., McIntosh, K., Patil, S., Hardy, W., Devine, S., Ucker, D., Deans, R., Moseley, A., and Hoffman, R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30, 42, 2002.
37. Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P.D., Matteucci, P., Grisanti, S., and Gianni, A.M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or non-specific mitogenic stimuli. Blood 99, 3838, 2002.
38. Devine, S.M., Peter, S., Martin, B.J., Barry, F., and McIntosh, K.R. Mesenchymal stem cells: stealth and suppression. Cancer J. 9, 76, 2001.
39. McIntosh, K., and Bartholomew, A. Stromal cell modulation of the immune system. A potential role for mesenchymal stem cells. Graft 3, 324, 2000.
40. Arinzeh, T.L., Peter, S.J., Archambault, M.P., Van Der Bos, C., Gordon, S., Kraus, K., Smith, A., and Kadiyala, S. Allogenic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J. Bone Joint Surg. 85A, 1927, 2003.
41. Tsuchida, H., Hashimoto, J., Crawford, E., Manske, P., and Lou, J. Engineered allogenic mesenchymal stem cells repair femoral segmental defect in rats. J. Orthop. Res. 21, 44-53, 2003.